Nepicastat (SYN-117) HCl
99%
- Product Code: 101627
CAS:
170151-24-3
| Molecular Weight: | 331.81 g./mol | Molecular Formula: | C₁₄H₁₅F₂N₃SHCl |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00954638 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Nepicastat (SYN-117) HCl is primarily investigated for its potential in treating conditions related to the central nervous system. It acts as a selective inhibitor of dopamine β-hydroxylase, an enzyme involved in the conversion of dopamine to norepinephrine. By inhibiting this enzyme, it may help regulate neurotransmitter levels, making it a candidate for addressing stress-related disorders, such as post-traumatic stress disorder (PTSD). Research has shown its potential to reduce symptoms like anxiety and fear memory retention in preclinical studies. Additionally, it is being explored for its role in managing cardiovascular conditions, as it may influence sympathetic nervous system activity. Its application in these areas highlights its dual therapeutic potential in both neurological and cardiovascular health.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £109.72 |
+
-
|
Nepicastat (SYN-117) HCl
Nepicastat (SYN-117) HCl is primarily investigated for its potential in treating conditions related to the central nervous system. It acts as a selective inhibitor of dopamine β-hydroxylase, an enzyme involved in the conversion of dopamine to norepinephrine. By inhibiting this enzyme, it may help regulate neurotransmitter levels, making it a candidate for addressing stress-related disorders, such as post-traumatic stress disorder (PTSD). Research has shown its potential to reduce symptoms like anxiety and fear memory retention in preclinical studies. Additionally, it is being explored for its role in managing cardiovascular conditions, as it may influence sympathetic nervous system activity. Its application in these areas highlights its dual therapeutic potential in both neurological and cardiovascular health.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :